Mirabella Financial Services’s Cardiff Oncology CRDF Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-39,425
Closed -$709K 311
2020
Q4
$709K Buy
39,425
+21,177
+116% +$372K 0.09% 154
2020
Q3
$259K Buy
+18,248
New +$121K 0.04% 232

Other funds holding CRDF

Mirabella Financial Services's CRDF Position: Q1 2021 in Review

Mirabella Financial Services sold out of Cardiff Oncology (CRDF) in Q1 2021, closing a stake of 39,425 shares — an estimated $709K sold.

Mirabella Financial Services first reported a position in CRDF in Q3 2020 and held it in 2 quarters. The position peaked at $709K in Q4 2020. 73 funds tracked by Wall St. Rank hold CRDF as of Q1 2021.

  • Mirabella Financial Services reported no remaining Cardiff Oncology position as of Q1 2021 after selling out during the quarter.
  • Mirabella Financial Services sold 39,425 Cardiff Oncology shares in Q1 2021, an estimated $709K.
  • Mirabella Financial Services first reported a position in Cardiff Oncology in Q3 2020 and held it in 2 quarters.
  • Mirabella Financial Services's Cardiff Oncology position peaked at $709K in Q4 2020.
  • 73 funds tracked by Wall St. Rank held Cardiff Oncology as of Q1 2021.

Based on Mirabella Financial Services's 13F filing for Q1 2021, filed 17 May 2021.